Association of Smoking on Sputum Conversion Rate in Patient with Drug Sensitive Pulmonary Tuberculosis
DOI:
https://doi.org/10.70749/ijbr.v3i7.2967Keywords:
Mycobacterium tuberculosis, Smoking, Sputum, Tuberculosis, Treatment outcomeAbstract
Background: Pulmonary tuberculosis is a common infectious disease and still a major public health problem in developing countries. Smoking is an important risk factor which impair lung defence and immune response, leading to poor treatment outcomes and delayed recovery in patients. Objective: To determine the association of smoking on sputum conversion rate in patients with drug sensitive pulmonary tuberculosis. Study Design: Prospective cohort study. Duration and Place of Study: This study was conducted from 26th March 2025 to 26th June 2025 at Department of Pulmonology, Lady Reading Hospital, Peshawar. Methodology: A total of 144 patients aged 18–60 years were included, with 72 smokers and 72 non-smokers. Diagnosis was made on chest X-ray and microbiological confirmation, and all patients received standard anti-tuberculous therapy. Sputum conversion was assessed after two months of treatment. Data were analysed using SPSS version 26. Chi-square test and Fisher exact test were applied. Results: Mean age of smokers was 39.86 ± 12.82 years and non-smokers were 40.46 ± 11.94 years. Sputum conversion was observed in 51 (70.8%) smokers and 60 (83.3%) non-smokers with relative risk 0.85 (95% CI: 0.71–1.02) and p = 0.074. Among males, conversion was significantly lower in smokers 51 (70.8%) compared to non-smokers 34 (97.1%) (p = 0.002). Conclusion: Smoking show negative effect on sputum conversion and delay treatment response in pulmonary tuberculosis, although overall association was not statistically significant.
Downloads
References
1. Yadav P, Gupta AK, Gautam AK, Arya S, Kumar A, Mishra AK, et al. Assessment of psychiatric illness among pulmonary tuberculosis patients at a tertiary care center in India. Ann Afr Med. 2024;23(4):594-599.
https://doi.org/10.4103/aam.aam_18_24
2. Ullah H, Ahmed H, Salman A, Iqbal R, Hussaini SJ, Malikzai A. The rising tide of tuberculosis in Pakistan: factors, impact, and multi-faceted approaches for prevention and control. Health Sci Rep. 2024;7(10):e70130.
https://doi.org/10.1002/hsr2.70130
3. Ticlla MR, Hella J, Hiza H, Sasamalo M, Mhimbira F, Rutaihwa LK, et al. The sputum microbiome in pulmonary tuberculosis and its association with disease manifestations: a cross-sectional study. Front Microbiol. 2021; 12:633396.
https://doi.org/10.3389/fmicb.2021.633396
4. Rathored J, Sharma SK, Banavaliker JN, Sreenivas V, Srivastava AK. Response to treatment and low serum vitamin D levels in North Indian patients with treatment-naive category I and multi-drug resistant pulmonary tuberculosis. Ann Med. 2024;56(1):2407066.
https://doi.org/10.1080/07853890.2024.2407066
5. Willemse D, Moodley C, Mehra S, Kaushal D. Transcriptional response of Mycobacterium tuberculosis to cigarette smoke condensate. Front Microbiol. 2021; 12:744800.
https://doi.org/10.3389/fmicb.2021.744800
6. Quan DH, Kwong AJ, Hansbro PM, Britton WJ. No smoke without fire: the impact of cigarette smoking on the immune control of tuberculosis. Eur Respir Rev. 2022;31(164):210252. https://doi.org/10.1183/16000617.0252-2021
7. Bai X, Verma D, Garcia C, Musheyev A, Kim K, Fornis L, et al. Ex vivo and in vivo evidence that cigarette smoke-exposed T regulatory cells impair host immunity against Mycobacterium tuberculosis. Front Cell Infect Microbiol. 2023; 13:1216492.
https://doi.org/10.3389/fcimb.2023.1216492
8. Romo ML, LaHood A, Stagg HR, Mitnick CD, Trevisi L, Hewison C, et al. Effect of smoking on drug-resistant tuberculosis treatment outcomes and potential mechanistic pathways: a multicountry cohort study. BMJ Open Respir Res. 2025;12(1):e003777.
https://doi.org/10.1136/bmjresp-2025-003777
9. Merid MW, Muluneh AG, Kassa GM. Alcohol drinking delays the rate of sputum smear conversion among DR-TB patients in northwest Ethiopia; a retrospective follow-up study. PLoS One. 2022;17(3):e0264852.
https://doi.org/10.1371/journal.pone.0264852
10. Ibrahim MN, Nik Husain NR, Daud A, Chinnayah T. Epidemiology and risk factors of delayed sputum smear conversion in Malaysian aborigines with smear-positive pulmonary tuberculosis. Int J Environ Res Public Health. 2022;19(4):2365. https://doi.org/10.3390/ijerph19042365
11. Bellanca CM, Polosa SP, Augello E, Di Benedetto G, Burgaletto C, Cantone AF, et al. A scoping review about smoking, smoking cessation and their effects on anti-tuberculosis agents: insights into drug metabolisms, safety, and effectiveness. Front Pharmacol. 2025; 16:1606150.
https://doi.org/10.3389/fphar.2025.1606150
12. Shinde M, Dixit S, Patel M, Sharma A, Satam J, Patil Y, et al. Relationship between smoking and pulmonary tuberculosis based on positive sputum smears. GMS Hyg Infect Control. 2024;19:Doc58.
https://doi.org/10.3205/dgkh000513
13. Cailleaux-Cezar M, Loredo C, Silva JRLE, Conde MB. Impact of smoking on sputum culture conversion and pulmonary tuberculosis treatment outcomes in Brazil: a retrospective cohort study. J Bras Pneumol. 2018;44(2):99-105
https://doi.org/10.1590/s1806-37562017000000161
14. Abal AT, Jayakrishnan B, Parwer S, El Shamy A, Abahussain E, Sharma PN. Effect of cigarette smoking on sputum smear conversion in adults with active pulmonary tuberculosis. Respir Med. 2005;99(4):415–420.
https://doi.org/10.1016/j.rmed.2004.08.016
15. Magee MJ, Kempker RR, Kipiani M, Tukvadze N, Howards PP, Narayan KMV, et al. Diabetes mellitus, smoking status, and rate of sputum culture conversion in patients with multidrug-resistant tuberculosis: a cohort study from the country of Georgia. PLoS One. 2014;9(4):e94890.
https://doi.org/10.1371/journal.pone.0094890
16. Wang EY, Arrazola RA, Mathema B, Ahluwalia IB, Mase SR. The impact of smoking on tuberculosis treatment outcomes: a meta-analysis. Int J Tuberc Lung Dis. 2020;24(2):170–175.
https://doi.org/10.5588/ijtld.19.0002
17. Abal AT, Jayakrishnan B, Parwer S, El Shamy A, Abahussain E, Sharma PN. Effect of cigarette smoking on sputum smear conversion in adults with active pulmonary tuberculosis. Respir Med. 2005;99(4):415-420.
https://doi.org/10.1016/j.rmed.2004.08.016
18. Siddiqui UA, O’Toole M, Kabir Z, Qureshi S, Gibbons N, Kane M, et al. Smoking prolongs the infectivity of patients with tuberculosis. Ir Med J. 2010;103(9):278–280
19. Mahishale V, Patil B, Lolly M, Eti A, Khan S. Prevalence of smoking and its impact on treatment outcomes in newly diagnosed pulmonary tuberculosis patients: a hospital-based prospective study. Chonnam Med J. 2015;51(2):86–90.
https://doi.org/10.4068/cmj.2015.51.2.86
20. Paik G, Sau M, Kumari K, Ajila AS, Debbarma S. Sputum smear conversion and its associated factors among sputum-positive pulmonary tuberculosis patients of a tribal community in West Bengal. Asian J Med Sci. 2025;16(9):65–??
https://doi.org/10.71152/ajms.v16i9.4679
21. Mota PC, Carvalho A, Valente I, Braga R, Duarte R. Predictors of delayed sputum smear and culture conversion among a Portuguese population with pulmonary tuberculosis. Rev Port Pneumol. 2012;18(2):72–79.
https://doi.org/10.1016/j.rppneu.2011.12.005
22. Buatong W, Chaimay B, Woradet S. Determinants of sputum smear non-conversion after intensive phase treatment among pulmonary TB patients in southern Thailand. J Infect Dev Ctries. 2026;20(2):175–182.
https://doi.org/10.3855/jidc.21793
23. Fitriani L, Nadirahilah, Harwati AR. Smoking and increased symptoms of pulmonary TB: a retrospective analysis at Cibinong Hospital. J Health Sci. 2024;5(12):890–902
https://doi.org/10.46799/jhs.v5i12.2677
24. Hassmiller KM. The association between smoking and tuberculosis. Salud Publica Mex. 2006;48(Suppl 1):S201–S216.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Indus Journal of Bioscience Research
This work is licensed under a Creative Commons Attribution 4.0 International License.
